Kitov Pharmaceuticals (NASDAQ: KTOV), an innovative biopharmaceutical company focused on late-stage drug development, today announced that it has entered into ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE